Search

everythinglearnresearchcommunity

for

Search:↓

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Possible link between androgens and COVID-19 severity; more research needed.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Children's screen time increased during the pandemic, causing various health issues.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

The treatment might help COVID-19 related hair loss, but more research is needed.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.